Ocular Therapeutix logo

Ocular Therapeutix share price today

(OCUL)

Ocular Therapeutix share price is $8.88 & ₹761.99 as on 7 Jan 2025, 2.30 'hrs' IST

$8.88

▲

0.12

(1.37%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Ocular Therapeutix share price in Dollar and Rupees. Guide to invest in Ocular Therapeutix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ocular Therapeutix, along with analyst recommendations, forecasts, and comprehensive financials.

Ocular Therapeutix share price movements

  • Today's Low: $8.85
    Today's High: $9.15

    Day's Volatility :3.29%

  • 52 Weeks Low: $3.76
    52 Weeks High: $11.78

    52 Weeks Volatility :68.07%

Ocular Therapeutix Returns

PeriodOcular Therapeutix IncSector (Health Care)Index (Russel 2000)
3 Months
-6.01%
-8.4%
0.0%
6 Months
35.81%
-3.8%
0.0%
1 Year
84.81%
-0.1%
0.0%
3 Years
35.39%
2.9%
-19.8%

Ocular Therapeutix Key Statistics

in dollars & INR

Previous Close
$8.76
Open
$8.86
Today's High
$9.1513
Today's Low
$8.85
Market Capitalization
$1.3B
Today's Volume
$534.3K
52 Week High
$11.775
52 Week Low
$3.7599
Revenue TTM
$61.1M
EBITDA
$-110.7M
Earnings Per Share (EPS)
$-1.29
Profit Margin
-226.46%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-72.67%

How to invest in Ocular Therapeutix from India?

It is very easy for Indian residents to invest directly in Ocular Therapeutix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ocular Therapeutix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ocular Therapeutix or OCUL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ocular Therapeutix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ocular Therapeutix shares which would translate to 0.097 fractional shares of Ocular Therapeutix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ocular Therapeutix, in just a few clicks!

Returns in Ocular Therapeutix for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ocular Therapeutix investment value today

Current value as on today

₹1,90,564

Returns

₹90,564

(+90.56%)

Returns from Ocular Therapeutix Stock

₹87,342 (+87.34%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Ocular Therapeutix

25%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Ocular Therapeutix on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 25% more investors are searching Ocular Therapeutix in the last 30 days versus the previous period.

Global Institutional Holdings in Ocular Therapeutix

  • SUMMER ROAD LLC

    9.16%

  • VR Adviser, LLC

    8.12%

  • Deep Track Capital, LP

    8.09%

  • BlackRock Inc

    7.33%

  • Vanguard Group Inc

    5.33%

  • venBio Select Advisor LLC

    5.13%

Analyst Recommendation on Ocular Therapeutix

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Ocular Therapeutix(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Ocular Therapeutix

What analysts predicted

Upside of 105.2%

Current:

$8.88

Target:

$18.22

Insights on Ocular Therapeutix

  • Price Movement

    In the last 1 year, OCUL stock has moved up by 99.1%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 16.44M → 15.42M (in $), with an average decrease of 6.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -64.84M → -36.49M (in $), with an average increase of 34.1% per quarter

  • OCUL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 22.3%

Ocular Therapeutix Financials in INR & Dollars

FY18Y/Y Change
Revenue
$2.0M
↑ 3.48%
Net Income
$-57.7M
↓ 8.98%
Net Profit Margin
-2.9K%
↑ 397.1%
FY19Y/Y Change
Revenue
$4.2M
↑ 112.41%
Net Income
$-89.9M
↑ 55.89%
Net Profit Margin
-2.1K%
↑ 771.47%
FY20Y/Y Change
Revenue
$17.4M
↑ 311.71%
Net Income
$-159.6M
↑ 77.5%
Net Profit Margin
-917.26%
↑ 1210.37%
FY21Y/Y Change
Revenue
$43.5M
↑ 150.08%
Net Income
$-10.8M
↓ 93.23%
Net Profit Margin
-24.82%
↑ 892.44%
FY22Y/Y Change
Revenue
$51.5M
↑ 18.32%
Net Income
$-63.4M
↑ 487.02%
Net Profit Margin
-123.16%
↓ 98.34%
FY23Y/Y Change
Revenue
$58.4M
↑ 13.49%
Net Income
$-80.7M
↑ 27.3%
Net Profit Margin
-138.14%
↓ 14.98%
Q2 FY23Q/Q Change
Revenue
$15.2M
↑ 13.55%
Net Income
$-20.7M
↓ 43.18%
Net Profit Margin
-136.19%
↑ 135.96%
Q3 FY23Q/Q Change
Revenue
$15.0M
↓ 1.55%
Net Income
$-516.0K
↓ 97.51%
Net Profit Margin
-3.45%
↑ 132.74%
Q4 FY23Q/Q Change
Revenue
$14.8M
↓ 0.99%
Net Income
$-29.2M
↑ 5562.79%
Net Profit Margin
-197.41%
↓ 193.96%
Q1 FY24Q/Q Change
Revenue
$14.7M
↓ 0.59%
Net Income
$-64.8M
↑ 121.93%
Net Profit Margin
-440.69%
↓ 243.28%
Q2 FY24Q/Q Change
Revenue
$16.4M
↑ 11.73%
Net Income
$-43.8M
↓ 32.49%
Net Profit Margin
-266.27%
↑ 174.42%
Q3 FY24Q/Q Change
Revenue
$15.4M
↓ 6.18%
Net Income
$-36.5M
↓ 16.64%
Net Profit Margin
-236.58%
↑ 29.69%
FY18Y/Y Change
Profit
$1.5M
↑ 4.02%
FY19Y/Y Change
Profit
$1.9M
↑ 24.72%
FY20Y/Y Change
Profit
$15.3M
↑ 705.47%
FY21Y/Y Change
Profit
$39.1M
↑ 155.33%
FY22Y/Y Change
Profit
$47.0M
↑ 20.04%
FY23Y/Y Change
Profit
$53.2M
↑ 13.22%
Q2 FY23Q/Q Change
Profit
$13.9M
↑ 14.16%
Q3 FY23Q/Q Change
Profit
$13.6M
↓ 2.23%
Q4 FY23Q/Q Change
Profit
$13.4M
↓ 1.16%
Q1 FY24Q/Q Change
Profit
$13.4M
↓ 0.2%
Q2 FY24Q/Q Change
Profit
$14.9M
↑ 11.52%
Q3 FY24Q/Q Change
Profit
$13.9M
↓ 7.15%
FY18Y/Y Change
Operating Cash Flow
$-49.2M
↓ 2.47%
Investing Cash Flow
$-1.9M
↓ 106.98%
Financing Cash Flow
$68.6M
↑ 114.45%
FY19Y/Y Change
Operating Cash Flow
$-77.6M
↑ 57.59%
Investing Cash Flow
$-2.2M
↑ 18.48%
Financing Cash Flow
$75.3M
↑ 9.76%
FY20Y/Y Change
Operating Cash Flow
$-53.6M
↓ 30.97%
Investing Cash Flow
$-841.0K
↓ 62.42%
Financing Cash Flow
$228.0M
↑ 202.64%
FY21Y/Y Change
Operating Cash Flow
$-65.6M
↑ 22.4%
Investing Cash Flow
$-1.2M
↑ 41.97%
Financing Cash Flow
$2.9M
↓ 98.75%
FY22Y/Y Change
Operating Cash Flow
$-59.6M
↓ 9.07%
Investing Cash Flow
$-3.7M
↑ 211.14%
Financing Cash Flow
$1.5M
↓ 49.0%
Q2 FY23Q/Q Change
Operating Cash Flow
$-20.1M
↑ 0.51%
Investing Cash Flow
$-2.0M
↓ 41.11%
Financing Cash Flow
$9.6M
↑ 12265.38%

Ocular Therapeutix Technicals Summary

Sell

Neutral

Buy

Ocular Therapeutix is currently in a neutral trading position according to technical analysis indicators.

Ocular Therapeutix Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ocular Therapeutix Inc
Ocular Therapeutix Inc
-6.31%
35.81%
84.81%
35.39%
98.64%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ocular Therapeutix Inc
Ocular Therapeutix Inc
NA
NA
0.0
-1.07
-0.73
-0.22
NA
0.79
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ocular Therapeutix Inc
Ocular Therapeutix Inc
Buy
$1.3B
98.64%
NA
-226.46%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Ocular Therapeutix

ocular therapeutix, inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. ocular therapeutix’s lead product candidate, dextenza™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. otx-tp (travoprost insert) is in phase 3 clinical development for the reduction of intraocular pressure in patients with glaucoma and ocular hypertension. the company’s earlier stage assets include otx-tic, a sustained release travoprost intracameral injection for the reduction in intraocular pressure in patients with glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. these injections include the development of otx-tki, a tyrosine kinase inhib
Organization
Ocular Therapeutix
Employees
267
CEO
Mr. Donald Notman Jr.
Industry
Health Technology

Management People of Ocular Therapeutix

NameTitle
Mr. Donald Notman Jr.
CFO, COO & Principal Accounting Officer
Dr. Jeffrey S. Heier M.D.
Chief Scientific Officer
Dr. Pravin U. Dugel M.D.
Executive Chairman, President & CEO
Dr. Peter K. Jarrett Ph.D.
Chief Technology Officer
Mr. William S. Slattery Jr.
Vice President of Investor Relations
Mr. William H. Ransone II
Vice President of Global Sales & Marketing
Ms. Tracy Smith
Vice President of Human Resources
Mr. Steve Meyers
Chief Commercial Officer
Dr. Peter K. Kaiser M.D.
Chief Development Officer
Mr. Sanjay Nayak MBBS, Ph.D.
Chief Strategy Officer

Important FAQs about investing in Ocular Therapeutix from India :

What is Ocular Therapeutix share price today?

Ocular Therapeutix share price today stands at $8.88, Open: $8.86 ; Previous Close: $8.76 ; High: $9.15 ; Low: $8.85 ; 52 Week High: $11.78 ; 52 Week Low: $3.76. The stock opens at $8.86, after a previous close of $8.76. The stock reached a daily high of $9.15 and a low of $8.85, with a 52-week high of $11.78 and a 52-week low of $3.76.

Can Indians buy Ocular Therapeutix shares?

Yes, Indians can invest in the Ocular Therapeutix (OCUL) from India.

With INDmoney, you can buy Ocular Therapeutix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ocular Therapeutix at zero transaction cost.

How can I buy Ocular Therapeutix shares from India?

It is very easy to buy Ocular Therapeutix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ocular Therapeutix be purchased?

Yes, you can buy fractional shares of Ocular Therapeutix with INDmoney app.

What are the documents required to start investing in Ocular Therapeutix stocks?

To start investing in Ocular Therapeutix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ocular Therapeutix

Today’s highest price of Ocular Therapeutix (OCUL) is $9.15.

Today’s lowest price of Ocular Therapeutix (OCUL) is $8.85.

What is today's market capitalisation of Ocular Therapeutix

Today's market capitalisation of Ocular Therapeutix OCUL is 1.3B

What is the 52 Week High and Low Range of Ocular Therapeutix

  • 52 Week High

    $11.78

  • 52 Week Low

    $3.76

What are the historical returns of Ocular Therapeutix?

  • 1 Month Returns

    -6.31%

  • 3 Months Returns

    35.81%

  • 1 Year Returns

    84.81%

  • 5 Years Returns

    98.64%

Who is the Chief Executive Officer (CEO) of Ocular Therapeutix

Mr. Donald Notman Jr. is the current Chief Executive Officer (CEO) of Ocular Therapeutix.